Boston, MA 02\/10\/2014 (wallstreetpr) – Alpha Natural Resources, Inc. (NYSE:ANR)<\/b> has had its rating adjusted upward by analysts at Citigroup Inc whereby it now carries a \u201cneutral\u201d tag, from a \u201csell\u201d in the previous view. The stock has a consensus \u201chold\u201d rating and average price target of $7.82. This follows views from at least 18 analysts that have recently commented on the stock. This consensus price target suggests a significant potential upside from the current price. The latest rating of ANR comes in the wake of an announcement that the company, through a subsidiary, was opening an office in London. This comes as the company laid out its foreign opportunities, citing that 40 percent of its revenue comes from exports and that the move to establish office in London is a critical step in optimizing Alpha Natural Resources, Inc. (NYSE:ANR)\u2019s business in order to build significant value for the shareholders.<\/p>\n
Aaron’s, Inc. (NYSE:AAN)<\/b> could be purchased for $2.3 billion by a Florida investment company. The company has received $30.50 per share purchase offer from Vintage Capital Management Inc. Shares of AAN closed at $28.32 on Friday after gaining 4.7 percent. This bid is coming at a time when AAN has had very challenging experiences in business of late. The company just reported suffering annual profit drop of 30 percent in 2013. The company is also worried about its future prospects as economic condition remains a trouble to the low and middle income consumers. Aaron\u2019s operates some 2,150 stores. Perhaps it is worth noting that Vintage which is offering to buy AAN is already invested in the company, holding 9.5 percent stake after investing about $196 million in acquiring 7.3 million shares of Aaron’s, Inc. (NYSE:AAN).<\/p>\n
Boston Scientific Corporation (NYSE:BSX)<\/b> is working on about seven new medical devices that the management hopes will maintain the company in financial success position in 2014. Thus, BSX hopes this will will just be as good as 2013. According to the CEO Michael Mahoney, the new devices and technology that the company is developing would generate more meaningful top line this year. The said upcoming products include valve replacement systems and stents. In this regard, Boston Scientific Corporation (NYSE:BSX) is reserving on words to speak about its bright future.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 02\/10\/2014 (wallstreetpr) – Alpha Natural Resources, Inc. (NYSE:ANR) has had its rating adjusted upward by analysts at Citigroup Inc whereby it now carries […]<\/p>\n","protected":false},"author":13,"featured_media":14869,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[4525,3552,2960,4526,3553,1020],"stock_ticker":[],"class_list":["post-14868","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-aarons-inc-nyseaan","tag-alpha-natural-resources-inc-nyseanr","tag-boston-scientific-corporation-nysebsx","tag-nyseaan","tag-nyseanr","tag-nysebsx","entry"],"acf":[],"yoast_head":"\n